Cancer stem cells and the tumor microenvironment: Soloists or choral singers

Current Pharmaceutical Biotechnology

Volumn 12, Issue 2, 2011, Pages 171-181

  Albini, A ^a   Cesana, E ^a   Noonan, D M ^b  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cancer stem cell; Matrigel; Microenvironment; miRNA; Models; Niche; Stemness control; Surface markers

Indexed keywords

BEVACIZUMAB; CELL SURFACE MARKER; GEMTUZUMAB OZOGAMICIN; MICRORNA; ONCOLYTIC VIRUS; ZILEUTON;

ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; CELL MATURATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE REPLICATION; GLIOBLASTOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; STEM CELL TRANSPLANTATION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 79551625321     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794295756     Document Type: Article

References (62)

1. Baker, M. Cancer stem cells, becoming common. Nat. Rep. Stem Cells, 2008.
2. Kawamura, T.; Suzuki, J.; Wang, Y.V.; Menendez, S.; Morera, L.B.; Raya, A.; Wahl, G.M.; Belmonte, J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 2009, 460(7259), 1140-1144.
3. Pece, S.; Tosoni, D.; Confalonieri, S.; Mazzarol, G.; Vecchi, M.; Ronzoni, S.; Bernard, L.; Viale, G.; Pelicci, P. G.; Di Fiore, P. P. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell, 2010, 140(1), 62-73.
4. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA, 2003, 100 (7), 3983-8.
5. Zucchi, I.; Astigiano, S.; Bertalot, G.; Sanzone, S.; Cocola, C.; Pelucchi, P.; Bertoli, G.; Stehling, M.; Barbieri, O.; Albertini, A.; Scholer, H. R.; Neel, B. G.; Reinbold, R. A.; Dulbecco, R. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells. Proc. Natl. Acad. Sci. USA, 2008, 105(44), 16940-16945.
6. Nakanishi, T.; Chumsri, S.; Khakpour, N.; Brodie, A.H.; Leyland- Jones, B.; Hamburger, A.W.; Ross, D. D.; Burger, A. M. Sidepopulation cells in luminal-type breast cancer have tumourinitiating cell properties, and are regulated by HER2 expression and signalling. Br. J. Cancer, 2010, 102(5),815-826.
7. Prat, A.; Perou, C. M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol., 2010, [Epub ahead of print].
8. Albini, A.; Melchiori, A.; Garofalo, A.; Noonan, D. M.; Basolo, F.; Taraboletti, G.; Chader, G. J.; Gavazzi, R. Matrigel promotes retinoblastoma cell growth in vitro and in vivo. Int. J. Cancer, 1992, 52(2), 234-240.
9. Fridman, R.; Kibbey, M.; Royce, L.; Zain, M.; Sweeney, T.; Jicha, D.; Yannelli, J.; Martin, G.; Kleinman, H. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with matrigel. J. Natl. Cancer Inst., 1991, 83, 769-774.
10. Ebos, J. M.; Lee, C. R.; Cruz-Munoz, W.; Bjarnason, G. A.; Christensen, J. G.; Kerbel, R. S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell, 2009, 15 (3), 232-239.
11. Paez-Ribes, M.; Allen, E.; Hudock, J.; Takeda, T.; Okuyama, H.; Vinals, F.; Inoue, M.; Bergers, G.; Hanahan, D.; Casanovas, O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell, 2009, 15(3), 220-231.
12. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres- Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367(6464), 645-648.
13. Castor, A.; Nilsson, L.; Astrand-Grundstrom, I.; Buitenhuis, M.; Ramirez, C.; Anderson, K.; Strombeck, B.; Garwicz, S.; Bekassy, A.N.; Schmiegelow, K.; Lausen, B.; Hokland, P.; Lehmann, S.; Juliusson, G.; Johansson, B.; Jacobsen, S.E. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat. Med., 2005, 11(6), 630-637.
14. Cobaleda, C.; Gutierrez-Cianca, N.; Perez-Losada, J.; Flores, T.; Garcia-Sanz, R.; Gonzalez, M.; Sanchez-Garcia, I. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood, 2000, 95(3), 1007-1013.
15. Cox, C. V.; Evely, R. S.; Oakhill, A.; Pamphilon, D. H.; Goulden, N. J.; Blair, A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood, 2004, 104(9), 2919-2925.
16. Fialkow, P. J.; Jacobson, R. J.; Papayannopoulou, T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med., 1977, 63(1), 125-130.
17. George, A. A.; Franklin, J.; Kerkof, K.; Shah, A. J.; Price, M.; Tsark, E.; Bockstoce, D.; Yao, D.; Hart, N.; Carcich, S.; Parkman, R.; Crooks, G. M.; Weinberg, K. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia. Blood, 2001, 97(12), 3925-3930.
18. Hotfilder, M.; Rottgers, S.; Rosemann, A.; Jurgens, H.; Harbott, J.; Vormoor, J. Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood, 2002, 100(2), 640-646.
19. Buzzeo, M. P.; Scott, E.W.; Cogle, C. R. The hunt for cancerinitiating cells: a history stemming from leukemia. Leukemia, 2007, 21(8), 1619-1627.
20. Clarke, M. F.; Dick, J. E.; Dirks, P. B.; Eaves, C. J.; Jamieson, C. H.; Jones, D. L.; Visvader, J.; Weissman, I. L.; Wahl, G. M. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res., 2006, 66(19), 9339-9344.
21. P.C. Foundations in cancer research. Chromosomes and cancer: the evolution of an idea. Adv. Cancer Res., 1993, 62, 1-17.
22. Fearon, E. R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 1990, 61 (5), 759-767.
23. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell, 2000, 100(1), 57-70.
24. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature, 2004, 432(7015), 396-401.
25. Yin, G.; Chen, R.; Alvero, A. B.; Fu, H. H.; Holmberg, J.; Glackin, C.; Rutherford, T.; Mor, G. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene, 2010, 29(24), 3545-3553
26. Riggi, N.; Suva, M. L.; De Vito, C.; Provero, P.; Stehle, J. C.; Baumer, K.; Cironi, L.; Janiszewska, M.; Petricevic, T.; Suva, D.; Tercier, S.; Joseph, J. M.; Guillou, L.; Stamenkovic, I. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev., 2010, 24(9), 916-932.
27. Chen, Y.; Hu, Y.; Zhang, H.; Peng, C.; Li, S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet., 2009, 41(7), 783-792.
28. Chen, Y.; Li, D.; Li, S. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell Cycle, 2009, 8(21), 3488-3492.
29. Cicalese, A.; Bonizzi, G.; Pasi, C. E.; Faretta, M.; Ronzoni, S.; Giulini, B.; Brisken, C.; Minucci, S.; Di Fiore, P. P.; Pelicci, P. G. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell, 2009, 138(6), 1083-1095.
30. Suva, M. L.; Riggi, N.; Janiszewska, M.; Radovanovic, I.; Provero, P.; Stehle, J. C.; Baumer, K.; Le Bitoux, M. A.; Marino, D.; Cironi, L.; Marquez, V. E.; Clement, V.; Stamenkovic, I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res., 2009, 69(24), 9211-9218.
31. Viale, A.; De Franco, F.; Orleth, A.; Cambiaghi, V.; Giuliani, V.; Bossi, D.; Ronchini, C.; Ronzoni, S.; Muradore, I.; Monestiroli, S.; Gobbi, A.; Alcalay, M.; Minucci, S.; Pelicci, P.G. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature, 2009, 457(7225), 51-56.
32. Nowell, P. C.; Hungerford, D.A. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst., 1960, 25, 85-109.
33. Kai, T.; Spradling, A. An empty Drosophila stem cell niche reactivates the proliferation of ectopic cells. Proc. Natl. Acad. Sci. USA, 2003, 100(8), 4633-4638.
34. Jiang, S.; Lee, B. C.; Fu, Y.; Avraham, S.; Lim, B.; Avraham, H. K. Reconstitution of mammary epithelial morphogenesis by murine embryonic stem cells undergoing hematopoietic stem cell differentiation. PLoS One, 2010, 5(3), e9707.
35. Boulanger, C. A.; Smith, G. H. Reprogramming cell fates in the mammary microenvironment. Cell Cycle, 2009, 8(8), 1127-1132.
36. Calabrese, C.; Poppleton, H.; Kocak, M.; Hogg, T. L.; Fuller, C.; Hamner, B.; Oh, E. Y.; Gaber, M. W.; Finklestein, D.; Allen, M.; Frank, A.; Bayazitov, I. T.; Zakharenko, S. S.; Gajjar, A.; Davidoff, A.; Gilbertson, R.J. A perivascular niche for brain tumor stem cells. Cancer Cell, 2007, 11(1), 69-82.
37. Bao, S.; Wu, Q.; Sathornsumetee, S.; Hao, Y.; Li, Z.; Hjelmeland, A. B.; Shi, Q.; McLendon, R. E.; Bigner, D. D.; Rich, J. N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res., 2006, 66(16), 7843-7848.
38. Schatton, T.; Murphy, G. F.; Frank, N. Y.; Yamaura, K.; Waaga- Gasser, A. M.; Gasser, M.; Zhan, Q.; Jordan, S.; Duncan, L. M.; Weishaupt, C.; Fuhlbrigge, R. C.; Kupper, T. S.; Sayegh, M. H.; Frank, M. H. Identification of cells initiating human melanomas. Nature, 2008, 451(7176), 345-349.
39. Zabierowski, S. E.; Herlyn, M. Learning the ABCs of melanomainitiating cells. Cancer Cell, 2008, 13(3), 185-187.
40. Hollier, B. G.; Evans, K.; Mani, S. A. The epithelial-tomesenchymal transition and cancer stem cells: a coalition against cancer therapies. J. Mammary Gland Biol. Neoplasia, 2009, 14(1), 29-43.
41. Mani, S.A.; Guo, W.; Liao, M. J.; Eaton, E. N.; Ayyanan, A.; Zhou, A.Y.; Brooks, M.; Reinhard, F.; Zhang, C. C.; Shipitsin, M.; Campbell, L. L.; Polyak, K.; Brisken, C.; Yang, J.; Weinberg, R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133(4), 704-715.
42. Dairkee, S. H.; Ljung, B. M.; Smith, H.; Hackett, A. Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease. Breast Cancer Res. Treat., 1987, 10(1), 11-20.
43. Korsching, E.; Jeffrey, S. S.; Meinerz, W.; Decker, T.; Boecker, W.; Buerger, H. Basal carcinoma of the breast revisited: an old entity with new interpretations. J. Clin. Pathol., 2008, 61(5), 553-560.
44. Santini, D.; Ceccarelli, C.; Taffurelli, M.; Pileri, S.; Marrano, D. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J. Pathol., 1996, 179(4), 386-391.
45. Boccaccio, C.; Comoglio, P. M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer, 2006, 6(8), 637-645.
46. Huff, C. A.; Matsui, W.; Smith, B. D.; Jones, R. J. The paradox of response and survival in cancer therapeutics. Blood, 2006, 107(2), 431-434.
47. Donnenberg, V. S.; Donnenberg, A. D. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol., 2005, 45(8), 872-877.
48. Ginestier, C.; Hur, M. H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C. G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M. S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 2007, 1(5), 555-567.
49. Kakarala, M.; Wicha, M. S. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J. Clin. Oncol., 2008, 26(17), 2813-2820.
50. Wang, S.; Yang, D.; Lippman, M. E. Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin. Oncol., 2003, 30(5 Suppl 16), 133-142.
51. Schulenburg, A.; Bramswig, K.; Herrmann, H.; Karlic, H.; Mirkina, I.; Hubmann, R.; Laffer, S.; Marian, B.; Shehata, M.; Krepler, C.; Pehamberger, H.; Grunt, T.; Jager, U.; Zielinski, C. C.; Valent, P. Neoplastic stem cells: Current concepts and clinical perspectives. Crit. Rev. Oncol. Hematol., 2010 Feb 23. [Epub ahead of print]
52. CBTRUS Statistical Report: Primary Brain Tumors in the United States, 2000-2004; 2008.
53. Dey, M.; Ulasov, I. V.; Lesniak, M.S. Virotherapy against malignant glioma stem cells. Cancer Lett., 289, (1), 1-10.
54. Dey, M.; Ulasov, I. V.; Tyler, M. A.; Sonabend, A. M.; Lesniak, M. S. Cancer Stem Cells: The final frontier for glioma virotherapy. Stem Cell Rev., 2010. [Epub ahead of print]
55. Nandi, S.; Ulasov, I. V.; Tyler, M.A.; Sugihara, A. Q.; Molinero, L.; Han, Y.; Zhu, Z. B.; Lesniak, M. S. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res., 2008, 68(14), 5778-5784.
56. Zhou, B.B.; Zhang, H.; Damelin, M.; Geles, K.G.; Grindley, J.C.; Dirks, P. B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov., 2009, 8(10), 806-823.
57. Gupta, P. B.; Chaffer, C. L.; Weinberg, R. A. Cancer stem cells: mirage or reality? Nat. Med., 2009, 15(9), 1010-1012.
58. Maenhaut, C.; Dumont, J. E.; Roger, P. P.; van Staveren, W. C. Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis, 2010, 31(2), 149-158.
59. Vezzoni, L.; Parmiani, G. Limitations of the cancer stem cell theory. Cytotechnology, 2008, 58(1), 3-9.
60. Blagosklonny, M. V. Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol. Ther., 2007, 6(11), 1684-1690.
61. Viale, A.; Pelicci, P. G. Awaking stem cells from dormancy: growing old and fighting cancer. EMBO Mol. Med., 2009, 1(2), 88-91.
62. Cruz, M.; Siden, Å.; Tasat, D.R.; Yakisich, J.S. Are all glioma cells cancer stem cells? J. Cancer Sci. Ther., 2010, 2, 100-106.